Steven Cohen Eagle Pharmaceuticals, Inc. Transaction History

Point72 Asset Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$17.74 - $31.87 $57,264 - $102,876	-3,228 Reduced 61.77%	1,998 $38,000
Q1 2023 May 15, 2023	BUY	$25.06 - $34.09 $130,963 - $178,154	5,226 New	5,226 $148,000
Q3 2019 Nov 15, 2019	SELL	$53.25 - $59.98 $1.52 Million - $1.71 Million	-28,534 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$46.61 - $58.45 $1.33 Million - $1.67 Million	28,534 New	28,534 $1.59 Million

8.6M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.